Test Bank For Seidel's Guide To Physical
Examination An Interprofessional
Approach 10th Edition 2025/2026 Latest
Update Already Graded A+
ANS: C
After Phase I studies demonstrating drug safety and pharmacokinetics have been
completed, the drug is tested on subjects who have the disease the drug is being
investigated to treat.
A clinical drug trial focused on determining the pharmacokinetics and safety of a drug in
healthy individuals is concluding. The nurse will assist with enrollment of participants into
the next phase of the study which will likely include which of the following subjects?
a. Healthy subjects
b. Healthy and subjects with the disease the drug is being studied to treat
c. Subjects with the disease the drug is being studied to treat
d. Subjects with other diseases
ANS: D
Phase IV studies are performed, in part, to examine potential new indications for
approved drugs.
Before marketing a new drug that has been approved for use based on clinical effectiveness
and safety, the manufacturer wishes to study the potential new uses for the drug. This is an
example of which phase of study?
a. Phase I
b. Phase II
c. Phase III
d. Phase IV
ANS: D
The U.S. Food and Drug Administration (FDA) Modernization Act of 1997 requires that
drugs intended for use in children be tested on children.
,Which statement about the safety and efficacy of medications in children is accurate?
a. Children cannot give consent, so clinical drug trials are not performed on
children.
b. Children can only be subjects in quasi-experimental clinical studies.
c. Data from adult clinical drug trials should be extrapolated to children.
d. Federal law requires that drugs indicated for use in children be tested on children.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting
a portion of a drug, another nurse should observe and cosign that a drug was wasted.
The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the
vial.
b. Keep the remaining amount in the patient's drawer to give at the next dose.
c. Record the amount unused in the patient's medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: D
The generic name is the official, nonproprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical
structure of the drug.
A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic drug name is
a. a registered trademark.
b. always capitalized.
c. related to the drug's chemical structure.
d. nonproprietary.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the
brand-name drug. They tend to be less expensive because manufacturers of these drugs
,do not have to do the extensive testing required of brand-name drugs before marketing.
They are not identical to brand-name drugs and often have different inert ingredients.
A patient receives a prescription on which the provider has noted that a generic medication
may be given. The patient asks the nurse what this means. What will the nurse tell the
patient about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are different from proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: D
The "USP" designation is given to drugs that have met high standards for therapeutic use,
patient safety, quality, purity, strength, packaging safety, and dosage form by the United
States Pharmacopoeia National Formulary. The FDA classifies controlled substances with
Roman numerals from I to V. The USP designation does not indicate FDA approval. The
USP designation does not indicate generic availability.
The nurse reviews information about a drug and notes the initials "United States
Pharmacopeia (USP)" after the drug's official name. The nurse understands that this
designation indicates the drug
a. is a controlled substance.
b. is approved by the FDA.
c. is available in generic form.
d. meets USP quality and safety standards.
ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.
The nurse is preparing to give a medication to a child. The medication is approved for use in
children. The child's parent asks whether the drug is safe for children. How will the nurse
respond to the parent?
a. "Drugs approved for use in children are tested on adults and safe doses for
children are based on weights compared to adult weights."
b. "Drugs approved for use in children are deemed safe for children over time when
, repeated use proves effectiveness and safety."
c. "Drugs approved for use in children are tested for both efficacy and safety in
children in order to be marketed for pediatric use."
d. "Drugs approved for use in children are tested on children in post-marketing
studies and on a limited basis."
ANS: C
Each state's Nurse Practice Act identifies how nurses administer medications. The other
acts govern how drugs are marketed and tested.
Which law(s) govern drug administration by nurses?
a. Drug Regulation and Reform Act.
b. FDA Amendments Act.
c. Nurse Practice Acts.
d. The Controlled Substances Act.
ANS: B
Methadone is a category II drug, with a high potential for drug abuse.
A patient is taking methadone as part of a heroin withdrawal program. The nurse
understands that, in this instance, methadone is classified as which drug schedule?
a. C-I
b. C-II
c. C-III d. C-V
ANS: B
Codeine is normally a category II drug, except when it is part of a combination product
such as with acetaminophen, making it a category III drug.
The nurse is preparing to administer a combination drug containing acetaminophen and
codeine. The nurse knows that this drug is classified as which drug schedule?
a. C-II
b. C-III
c. C-IV
d. C-V
Examination An Interprofessional
Approach 10th Edition 2025/2026 Latest
Update Already Graded A+
ANS: C
After Phase I studies demonstrating drug safety and pharmacokinetics have been
completed, the drug is tested on subjects who have the disease the drug is being
investigated to treat.
A clinical drug trial focused on determining the pharmacokinetics and safety of a drug in
healthy individuals is concluding. The nurse will assist with enrollment of participants into
the next phase of the study which will likely include which of the following subjects?
a. Healthy subjects
b. Healthy and subjects with the disease the drug is being studied to treat
c. Subjects with the disease the drug is being studied to treat
d. Subjects with other diseases
ANS: D
Phase IV studies are performed, in part, to examine potential new indications for
approved drugs.
Before marketing a new drug that has been approved for use based on clinical effectiveness
and safety, the manufacturer wishes to study the potential new uses for the drug. This is an
example of which phase of study?
a. Phase I
b. Phase II
c. Phase III
d. Phase IV
ANS: D
The U.S. Food and Drug Administration (FDA) Modernization Act of 1997 requires that
drugs intended for use in children be tested on children.
,Which statement about the safety and efficacy of medications in children is accurate?
a. Children cannot give consent, so clinical drug trials are not performed on
children.
b. Children can only be subjects in quasi-experimental clinical studies.
c. Data from adult clinical drug trials should be extrapolated to children.
d. Federal law requires that drugs indicated for use in children be tested on children.
ANS: A
Schedule II drugs are controlled substances, and all must be accounted for. When wasting
a portion of a drug, another nurse should observe and cosign that a drug was wasted.
The nurse is preparing to administer a schedule II injectable drug and is drawing up half of
the contents of a single-use vial. Which nursing action is correct?
a. Ask another nurse to observe and cosign wasting the remaining drug from the
vial.
b. Keep the remaining amount in the patient's drawer to give at the next dose.
c. Record the amount unused in the patient's medication record.
d. Dispose of the vial with the remaining drug into a locked collection box.
ANS: D
The generic name is the official, nonproprietary name for a drug. The brand name is the
trademark name and is always capitalized. The chemical name describes the chemical
structure of the drug.
A patient is prescribed a medication and asks the nurse if the drug is available in a generic
form. The nurse understands that a generic drug name is
a. a registered trademark.
b. always capitalized.
c. related to the drug's chemical structure.
d. nonproprietary.
ANS: C
Generic drugs are approved by the FDA if they are proved to be bioequivalent to the
brand-name drug. They tend to be less expensive because manufacturers of these drugs
,do not have to do the extensive testing required of brand-name drugs before marketing.
They are not identical to brand-name drugs and often have different inert ingredients.
A patient receives a prescription on which the provider has noted that a generic medication
may be given. The patient asks the nurse what this means. What will the nurse tell the
patient about generic drugs?
a. They contain the same inert ingredients as brand-name drugs.
b. They have chemical structures that are different from proprietary drugs.
c. They tend to be less expensive than brand-name drugs.
d. They undergo extensive testing before they are marketed.
ANS: D
The "USP" designation is given to drugs that have met high standards for therapeutic use,
patient safety, quality, purity, strength, packaging safety, and dosage form by the United
States Pharmacopoeia National Formulary. The FDA classifies controlled substances with
Roman numerals from I to V. The USP designation does not indicate FDA approval. The
USP designation does not indicate generic availability.
The nurse reviews information about a drug and notes the initials "United States
Pharmacopeia (USP)" after the drug's official name. The nurse understands that this
designation indicates the drug
a. is a controlled substance.
b. is approved by the FDA.
c. is available in generic form.
d. meets USP quality and safety standards.
ANS: C
The Pediatric Research Equity Act requires drug manufacturers to test drugs on children.
The nurse is preparing to give a medication to a child. The medication is approved for use in
children. The child's parent asks whether the drug is safe for children. How will the nurse
respond to the parent?
a. "Drugs approved for use in children are tested on adults and safe doses for
children are based on weights compared to adult weights."
b. "Drugs approved for use in children are deemed safe for children over time when
, repeated use proves effectiveness and safety."
c. "Drugs approved for use in children are tested for both efficacy and safety in
children in order to be marketed for pediatric use."
d. "Drugs approved for use in children are tested on children in post-marketing
studies and on a limited basis."
ANS: C
Each state's Nurse Practice Act identifies how nurses administer medications. The other
acts govern how drugs are marketed and tested.
Which law(s) govern drug administration by nurses?
a. Drug Regulation and Reform Act.
b. FDA Amendments Act.
c. Nurse Practice Acts.
d. The Controlled Substances Act.
ANS: B
Methadone is a category II drug, with a high potential for drug abuse.
A patient is taking methadone as part of a heroin withdrawal program. The nurse
understands that, in this instance, methadone is classified as which drug schedule?
a. C-I
b. C-II
c. C-III d. C-V
ANS: B
Codeine is normally a category II drug, except when it is part of a combination product
such as with acetaminophen, making it a category III drug.
The nurse is preparing to administer a combination drug containing acetaminophen and
codeine. The nurse knows that this drug is classified as which drug schedule?
a. C-II
b. C-III
c. C-IV
d. C-V
